Real-time enrollment status for this irritable bowel syndrome clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:11 AM UTC
| NCT Number | NCT03339128 |
| Recruiting Status | Recruiting |
| Condition | Irritable Bowel Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 95 participants |
| Active Locations | 26 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 19, 2025 (Sep 19, 2025) |
As of March 2, 2026: Clinical trial NCT03339128 is currently recruiting participants. This clinical trial study for irritable bowel syndrome is actively seeking new participants at 26 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03339128 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03339128 was last updated Sep 19, 2025 (September 19, 2025). HelloStudys verifies this status automatically.